Shares of Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $5.43 and traded as low as $4.90. Elekta AB (publ) shares last traded at $4.93, with a volume of 18,089 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a "strong sell" rating to a "hold" rating in a research note on Wednesday, January 29th.
Read Our Latest Stock Analysis on Elekta AB (publ)
Elekta AB (publ) Trading Up 4.8 %
The company's fifty day moving average is $5.35 and its two-hundred day moving average is $5.70. The company has a quick ratio of 0.81, a current ratio of 1.05 and a debt-to-equity ratio of 0.60. The stock has a market cap of $1.92 billion, a price-to-earnings ratio of 20.04 and a beta of 1.20.
Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last announced its quarterly earnings data on Friday, February 21st. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). The firm had revenue of $416.86 million during the quarter, compared to analyst estimates of $435.89 million. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%. On average, research analysts predict that Elekta AB will post 0.36 EPS for the current fiscal year.
Elekta AB (publ) Company Profile
(
Get Free Report)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
Featured Stories
Before you consider Elekta AB (publ), you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta AB (publ) wasn't on the list.
While Elekta AB (publ) currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
